ENSG Form 144: Proposed sale of 500 common shares

ENSG filed a Form 144 proposing the sale of 500 common shares tied to options granted 02/19/2021, with the method listed as cash.

Rhea-AI Filing Summary

ENSG filed a Form 144 proposing the sale of 500 common shares tied to options granted 02/19/2021, with the method listed as cash. The excerpt also shows prior sales by Beverly Wittekind: 8,400 shares on 12/12/2025 for $1,473,999.97 and 2,000 shares on 12/19/2025 for $360,000.00.

Insights

Insider Transactions Specialist

Form 144 records a proposed insider resale and recent insider sales.

The filing lists a proposed sale of 500 common shares associated with options granted on 02/19/2021, with the sale method noted as cash. This is a routine disclosure of an intended sale under Section 15(g).

Two prior transactions by Beverly Wittekind are shown: 8,400 shares on 12/12/2025 ($1,473,999.97) and 2,000 shares on 12/19/2025 ($360,000.00). Timing and cash‑flow recipients beyond the listed method are not detailed in the excerpt.

Corporate Governance Analyst

Disclosure is procedural; it documents an insider's planned resale and recent sales.

The entry identifies the broker address and NASDAQ listing, and records the security type as Common. The proposed sale is linked to options granted in 02/19/2021, vesting/exercise specifics are not shown in the excerpt.

Subsequent filings or Form 4/Form 5 entries may provide more detail on beneficial ownership or exercise mechanics; those details are not present here.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the ENSG Form 144 report?

The filing reports a proposed sale of 500 common shares tied to options granted on 02/19/2021. It also discloses recent insider sales of 8,400 and 2,000 shares on 12/12/2025 and 12/19/2025, respectively.

Who sold shares recently in the ENSG filing?

The excerpt names Beverly Wittekind as completing sales: 8,400 shares on 12/12/2025 for $1,473,999.97 and 2,000 shares on 12/19/2025 for $360,000.00. No other sellers are listed in the excerpt.

Are the proceeds from the proposed ENSG sale paid to the issuer?

The proposed sale method is listed as cash, indicating a cash transaction. The excerpt does not specify whether proceeds are paid to the issuer or to the selling holder, so the recipient of proceeds is not detailed here.

What option information does the ENSG Form 144 include?

The filing links the proposed sale to options granted on 02/19/2021 and lists 500 shares for sale with an action date of 02/19/2026. Additional exercise, vesting, or strike price details are not provided in the excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/19/2026 - 10:26 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001475842
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ENSIGN GROUP, INC
SEC File Number	001-33757
Address of Issuer	29222 RANCHO VIEJO RD. SUITE 127 SAN JUAN CAPISTRANO CALIFORNIA 92675
Phone	(949) 487-9500
Name of Person for Whose Account the Securities are To Be Sold	Wittekind Beverly B.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	500	105115.00	58112780	02/19/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/19/2026	Options Granted 02/19/2021	Issuer			500	02/19/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Beverly Wittekind 29222 Rancho Viejo Road Suite 127 San Juan Capistrano CA 92675	Common	12/12/2025	8400	1473999.97
Beverly Wittekind 29222 Rancho Viejo Road Suite 127 San Juan Capistrano CA 92675	Common	12/19/2025	2000	360000.00

144: Remarks and Signature

Remarks
Date of Notice	02/19/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/02/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Beverly Wittekind
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)